Downstream Process Development
Downstream processes for monoclonal antibodies, recombinant proteins, complex glycoproteins, bacteria and yeast, cell therapies, and viral vectors.
We have established downstream platforms that allow us to move quickly into a product’s manufacturing phase. Our experience also enables us to develop more customized and innovative solutions to meet our customers’ evolving needs.
We optimize our downstream processes to remove impurities and increase yields with minimal steps and optimal recovery, leading to more cost-efficient manufacturing.
Our process development and analytical teams are fully integrated to ensure we achieve the product quality attributes. One example includes our tailoring of processes to remove undesired product variants, such as under-sialylated molecules, aggregates and oxidation variants.